Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Connock

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Pharmacoeconomics|December 10, 2017
Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology AppraisalHema Mistry, Chidozie Nduka, Martin Connock, et al.
Diabetes Care|March 2, 2011
Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes: a systematic review and meta-analysis of the European Depression in Diabetes (EDID) Research ConsortiumArie Nouwen, Giesje Nefs, Isabela Caramlau, et al.
Pharmacoeconomics|February 13, 2020
Ocrelizumab for Treating Patients with Primary Progressive Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology AppraisalPeter Auguste, Jill Colquitt, Martin Connock, et al.
Pharmacoeconomics|March 28, 2018
Ixazomib for Relapsed or Refractory Multiple Myeloma: Review from an Evidence Review Group on a NICE Single Technology AppraisalXavier Armoiry, Martin Connock, Alexander Tsertsvadze, et al.
Plos One|July 9, 2014
Total hip replacement for the treatment of end stage arthritis of the hip: a systematic review and meta-analysisAlexander Tsertsvadze, Amy Grove, Karoline Freeman, et al.
ESC Heart Failure|May 12, 2026
Cost-effectiveness of TTVR with EVOQUE system in patients with Severe Tricuspid Regurgitation based on TRISCEND II trialApolline Grangeon, Martin Connock, Peter Auguste, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP|March 26, 2002
Mannosomes: a molluscan intracellular tubular membrane system related to heavy metal stress?Thomas Knigge, Neelam Mann, Zahida Parveen, et al.
Pharmacoeconomics|November 15, 2018
Autologous Chondrocyte Implantation with Chondrosphere for Treating Articular Cartilage Defects in the Knee: An Evidence Review Group Perspective of a NICE Single Technology AppraisalXavier Armoiry, Ewen Cummins, Martin Connock, et al.
International Journal of Technology Assessment in Health Care|December 13, 2022
Is the assumption of waning of treatment effect applied consistently across NICE technology appraisals? A case-study focusing on disease-modifying therapies for treatment of multiple sclerosisXavier Armoiry, Xia Wang-Steverding, Martin Connock, et al.
Frontiers in Pediatrics|April 5, 2021
Newborn Screening for Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase and Mitochondrial Trifunctional Protein Deficiencies Using Acylcarnitines Measurement in Dried Blood Spots-A Systematic Review of Test AccuracyChris Stinton, Hannah Fraser, Julia Geppert, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Pharmacoeconomics|December 10, 2017
Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology AppraisalHema Mistry, Chidozie Nduka, Martin Connock, et al.
Diabetes Care|March 2, 2011
Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes: a systematic review and meta-analysis of the European Depression in Diabetes (EDID) Research ConsortiumArie Nouwen, Giesje Nefs, Isabela Caramlau, et al.
Pharmacoeconomics|February 13, 2020
Ocrelizumab for Treating Patients with Primary Progressive Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology AppraisalPeter Auguste, Jill Colquitt, Martin Connock, et al.
Pharmacoeconomics|March 28, 2018
Ixazomib for Relapsed or Refractory Multiple Myeloma: Review from an Evidence Review Group on a NICE Single Technology AppraisalXavier Armoiry, Martin Connock, Alexander Tsertsvadze, et al.
Plos One|July 9, 2014
Total hip replacement for the treatment of end stage arthritis of the hip: a systematic review and meta-analysisAlexander Tsertsvadze, Amy Grove, Karoline Freeman, et al.
ESC Heart Failure|May 12, 2026
Cost-effectiveness of TTVR with EVOQUE system in patients with Severe Tricuspid Regurgitation based on TRISCEND II trialApolline Grangeon, Martin Connock, Peter Auguste, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP|March 26, 2002
Mannosomes: a molluscan intracellular tubular membrane system related to heavy metal stress?Thomas Knigge, Neelam Mann, Zahida Parveen, et al.
Pharmacoeconomics|November 15, 2018
Autologous Chondrocyte Implantation with Chondrosphere for Treating Articular Cartilage Defects in the Knee: An Evidence Review Group Perspective of a NICE Single Technology AppraisalXavier Armoiry, Ewen Cummins, Martin Connock, et al.
International Journal of Technology Assessment in Health Care|December 13, 2022
Is the assumption of waning of treatment effect applied consistently across NICE technology appraisals? A case-study focusing on disease-modifying therapies for treatment of multiple sclerosisXavier Armoiry, Xia Wang-Steverding, Martin Connock, et al.
Frontiers in Pediatrics|April 5, 2021
Newborn Screening for Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase and Mitochondrial Trifunctional Protein Deficiencies Using Acylcarnitines Measurement in Dried Blood Spots-A Systematic Review of Test AccuracyChris Stinton, Hannah Fraser, Julia Geppert, et al.
Pageof 5